middle.news
EMVision Accelerates Brain Scanner Trial with US Ethics Approval
8:19am on Wednesday 12th of February, 2025 AEDT
•
Healthcare
Read Story
EMVision Accelerates Brain Scanner Trial with US Ethics Approval
8:19am on Wednesday 12th of February, 2025 AEDT
Key Points
US central IRB ethics approval granted for pivotal EMVision emu™ brain scanner trial
Trial designated non-significant risk (NSR), enabling faster start-up and enrolment
Australian ethics approval pending, expected soon
Trial activation targeted for March 2025 to support FDA De Novo clearance
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Emvision Medical Devices (ASX:EMV)
OPEN ARTICLE